ATE485832T1 - Glucoseisomerase zur behandlung von fructose- unverträglichkeit - Google Patents

Glucoseisomerase zur behandlung von fructose- unverträglichkeit

Info

Publication number
ATE485832T1
ATE485832T1 AT08707777T AT08707777T ATE485832T1 AT E485832 T1 ATE485832 T1 AT E485832T1 AT 08707777 T AT08707777 T AT 08707777T AT 08707777 T AT08707777 T AT 08707777T AT E485832 T1 ATE485832 T1 AT E485832T1
Authority
AT
Austria
Prior art keywords
glucose
eisomerase
fructose
treatment
fructose intolerance
Prior art date
Application number
AT08707777T
Other languages
English (en)
Inventor
Daniel Wyrobnik
Isaac Wyrobnik
Original Assignee
Vitacare Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39628203&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE485832(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vitacare Gmbh & Co Kg filed Critical Vitacare Gmbh & Co Kg
Application granted granted Critical
Publication of ATE485832T1 publication Critical patent/ATE485832T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52Isomerases (5)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06Enzymes
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/485Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y101/00Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/99Oxidoreductases acting on the CH-OH group of donors (1.1) with other acceptors (1.1.99)
    • C12Y101/99011Fructose 5-dehydrogenase (1.1.99.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0102Alpha-glucosidase (3.2.1.20)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01026Beta-fructofuranosidase (3.2.1.26), i.e. invertase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y503/00Intramolecular oxidoreductases (5.3)
    • C12Y503/01Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01005Xylose isomerase (5.3.1.5)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT08707777T 2007-02-20 2008-02-20 Glucoseisomerase zur behandlung von fructose- unverträglichkeit ATE485832T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007008664.6A DE102007008664B4 (de) 2007-02-20 2007-02-20 Mittel zur Anwendung bei Fructoseintoleranz
PCT/EP2008/001294 WO2008101672A2 (en) 2007-02-20 2008-02-20 Agent for use in the case of fructose intolerance

Publications (1)

Publication Number Publication Date
ATE485832T1 true ATE485832T1 (de) 2010-11-15

Family

ID=39628203

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08707777T ATE485832T1 (de) 2007-02-20 2008-02-20 Glucoseisomerase zur behandlung von fructose- unverträglichkeit

Country Status (17)

Country Link
US (10) US8460911B2 (de)
EP (5) EP3295954B1 (de)
AT (1) ATE485832T1 (de)
CA (3) CA2716421C (de)
CY (1) CY1120085T1 (de)
DE (2) DE102007008664B4 (de)
DK (3) DK2289352T3 (de)
ES (4) ES2658123T3 (de)
HR (2) HRP20100733T1 (de)
HU (2) HUE041311T2 (de)
IL (1) IL200517A (de)
LT (1) LT2289352T (de)
PL (4) PL3456342T3 (de)
PT (3) PT3295954T (de)
RS (1) RS51896B (de)
SI (2) SI2289352T1 (de)
WO (1) WO2008101672A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951289B1 (de) * 2005-11-23 2018-11-14 Pro Natura Gesellschaft für Gesunde Ernährung mbH Mittel zur reduzierung des verwertbaren kaloriengehaltes von lebensmitteln und zur therapeutischen gewichtsreduktion, besonders im falle von adipositas (fettleibigkeit)
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
EP3269383A1 (de) 2008-09-04 2018-01-17 Stada Arzneimittel Ag Behandlung von fruktose-malabsorption
GB201417386D0 (en) 2014-10-01 2014-11-12 Nofima As Sugar-depleted fruit or vegetable juice product, method of producing the same and use thereof to maintain health and treat and to prevent medical ailments
FI127298B (en) 2016-06-23 2018-03-15 Fazer Ab Oy Karl An enzyme with fructan hydrolase activity
WO2019204486A1 (en) * 2018-04-18 2019-10-24 Baylor College Of Medicine Development of amyloglucosidase as a medicinal food or dietary supplement
WO2020168306A1 (en) * 2019-02-14 2020-08-20 Gutsybio Inc. Live biotherapeutics for the treatment of carbohydrate disorders

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083A (en) * 1849-02-06 Cooking-stove
GB1455993A (en) 1973-01-12 1976-11-17 Novo Industri As Glucose isomerase
US4396602A (en) 1981-09-22 1983-08-02 Asahi Kasei Kogyo Kabushiki Kaisha Blood glucose level lowering agents
SE8505783D0 (sv) 1985-12-06 1985-12-06 Rolf Bergkvist Forfarande for framstellning av livsmedelsprodukter och dessas anvendning
US5436003A (en) * 1994-02-10 1995-07-25 Triarco Industries, Inc. Method of alleviating gastrointestinal distress with a composition containing beta-fructofuransidase, cellulase and hemi-cellulase
EP1077609B1 (de) 1998-05-13 2008-07-09 Novozymes, Inc. Verfahren zur verwendung von cellobiosedehydrogenase beim backen
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
JP2000125883A (ja) * 1998-10-21 2000-05-09 Internatl Reagents Corp フルクトキナーゼ及びその遺伝子
AU6326699A (en) 1998-11-05 2000-05-29 Novozymes A/S Methods for using a glucose isomerase in baking
IL138990A0 (en) 1999-02-12 2001-11-25 Biostream Inc Matrices for drug delivery and methods for making and using the same
ATE283697T1 (de) 2000-03-01 2004-12-15 Nestle Sa Kohlenhydratformulierung (praebiotisches adjuvans) zur steigerung der immunantwort
US6646394B2 (en) 2001-07-09 2003-11-11 Nissan Motor Co., Ltd. Control device for plurality of rotating electrical machines
US20030113310A1 (en) 2001-12-17 2003-06-19 Van Laere Katrien Maria Jozefa Method for the treatment of obesity, overweight and fluctuations in blood insuline and/or glucose levels
US7067124B2 (en) 2003-03-28 2006-06-27 National Enzyme Company Protease composition and method for treating a digestive disorder
CA2669431C (en) 2005-11-16 2019-04-23 Pro Natura Gesellschaft Fuer Gesunde Ernaehrung Mbh Agent for use in the case of fructose intolerance
DE102006013624B4 (de) 2005-11-23 2012-03-15 Pro Natura Gesellschaft für gesunde Ernährung mbH Mittel zur Anwendung bei Fructoseintoleranz
US20090214620A1 (en) 2005-11-23 2009-08-27 Pro Natura Gesellschaft Fuer Gesunde Ernaehrung Mb Agent for use in the case of disorders of blood sugar metabolism, including diabetes
EP1951293B1 (de) * 2005-11-23 2015-09-09 Pro Natura Gesellschaft für Gesunde Ernährung mbH Mittel zur verwendung im fall von störungen des blutzuckerstoffwechsels, einschliesslich diabetes
EP1951289B1 (de) * 2005-11-23 2018-11-14 Pro Natura Gesellschaft für Gesunde Ernährung mbH Mittel zur reduzierung des verwertbaren kaloriengehaltes von lebensmitteln und zur therapeutischen gewichtsreduktion, besonders im falle von adipositas (fettleibigkeit)
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
US20090060656A1 (en) 2007-08-28 2009-03-05 Allied Tube & Conduit Corporation Paver edging device and method

Also Published As

Publication number Publication date
DE102007008664A1 (de) 2008-08-21
DE602008003199D1 (de) 2010-12-09
ES2783989T3 (es) 2020-09-21
EP3456342B1 (de) 2020-01-22
US8460911B2 (en) 2013-06-11
US9289474B2 (en) 2016-03-22
EP3295954A1 (de) 2018-03-21
US9155786B2 (en) 2015-10-13
DK3295954T3 (da) 2019-01-02
PL3295954T3 (pl) 2019-02-28
US20160243207A1 (en) 2016-08-25
PT2124640E (pt) 2011-01-13
HRP20180219T1 (hr) 2018-04-06
PT2289352T (pt) 2018-03-09
EP3295954B1 (de) 2018-09-12
ES2658123T3 (es) 2018-03-08
US20130302411A1 (en) 2013-11-14
US20090311232A1 (en) 2009-12-17
PL2289352T3 (pl) 2018-04-30
ES2700675T3 (es) 2019-02-18
CA2890721C (en) 2018-01-09
PT3295954T (pt) 2018-12-17
US9119860B2 (en) 2015-09-01
ES2356357T3 (es) 2011-04-07
US11826406B2 (en) 2023-11-28
IL200517A (en) 2016-06-30
US11147861B2 (en) 2021-10-19
US20180169197A1 (en) 2018-06-21
DK2289352T3 (en) 2018-02-12
SI2124640T1 (sl) 2011-03-31
US20130202695A1 (en) 2013-08-08
DK2124640T3 (da) 2011-01-31
EP2124640A2 (de) 2009-12-02
CA2984999A1 (en) 2008-08-28
CA2716421A1 (en) 2008-08-28
EP3456342A1 (de) 2019-03-20
CY1120085T1 (el) 2018-12-12
IL200517A0 (en) 2010-04-29
EP2289352A3 (de) 2011-05-25
DE102007008664B4 (de) 2021-07-29
HUE041311T2 (hu) 2019-05-28
PL3456342T3 (pl) 2020-06-15
WO2008101672A3 (en) 2009-06-18
EP3693005A1 (de) 2020-08-12
PL2124640T3 (pl) 2011-04-29
US20130202696A1 (en) 2013-08-08
HRP20100733T1 (hr) 2011-02-28
LT2289352T (lt) 2018-02-26
HUE10010195T2 (hu) 2018-07-30
US10842854B2 (en) 2020-11-24
CA2890721A1 (en) 2008-08-28
WO2008101672A2 (en) 2008-08-28
EP2289352B1 (de) 2017-11-29
EP2289352A2 (de) 2011-03-02
CA2716421C (en) 2015-07-21
US20170319668A1 (en) 2017-11-09
US20190282678A1 (en) 2019-09-19
EP2124640B1 (de) 2010-10-27
US20130202694A1 (en) 2013-08-08
SI2289352T1 (en) 2018-03-30
US20220072111A1 (en) 2022-03-10
RS51896B (en) 2012-02-29

Similar Documents

Publication Publication Date Title
ATE485832T1 (de) Glucoseisomerase zur behandlung von fructose- unverträglichkeit
WO2009105473A3 (en) Methods and devices for follow-up care and treatment of a pneumostoma
EA201101117A1 (ru) Ингибиторы дпп-4 для лечения диабета у детей
EA201001695A1 (ru) Применение эпотилона d для лечения заболеваний, связанных с тау-белком
EP4275752A3 (de) Behandlung von erkrankungen im zusammenhang mit sucht und impulskontrolle mittels pde7-inhibitoren
UA98629C2 (ru) Соединения и способ модуляции киназ
KZ24152B (en) Method of photosensitizer activation, treatment method with application of activated photosensitizer and photosensitizer application to prepare medicine
WO2006127007A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
WO2009056550A3 (en) Bupropion hydrobromide and therapeutic applications
WO2007028123A3 (en) Cochlear implant fitting
EP1891991A3 (de) Regelungsverfahren für die Eluierung von therapeutischen Wirkstoffen
MX2010001449A (es) Bromhidrato de bupropion y aplicaciones terapeuticas.
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2021203103A3 (en) Ace2 receptor polymorphisms and varying susceptibility to sars-cov-2, methods for diagnosis and treatment
JO3262B1 (ar) توليفة من ديسيتابين مع مثبط سيتيدين دي أميناز واستخدامها في علاج السرطان
UA92593C2 (ru) Лечение мастита энрофлоксацином
WO2007130501A3 (en) Combination therapy for treatment of cancer
EA200800722A1 (ru) Средство, активирующее стволовые клетки и/или клетки-предшественники
ES2570386T3 (es) Procedimiento de lucha biológica contra Pseusomonas
UA105940C2 (uk) Лікарська комбінація з теоброміном та опіатом і її використання в лікуванні кашлю
MA32355B1 (fr) Association de la dronedarone avec au moins un diuretique, son application en therapeutique
NZ598124A (en) Compounds for treatment of inflammation
WO2009105507A3 (en) Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
WO2006083667A3 (en) Treatment of oxygen induced inflammatory tissue injury
TR200804036U (tr) Arter tespit ateli.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2124640

Country of ref document: EP